Integrated transcriptomic analysis and RT-qPCR validation using FFPE patient tissues reveal the role of FOXQ1 and MCM10 in ovarian cancer
Eurasian Journal of Medicine and Oncology · 14.08.2026 · 10 (5) · 025470488
DOI: 10.36922/ejmo025470488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 14.08.2026. Verfasst von Dwi A. Suryandari und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Ovarian cancer has a high mortality rate due to late diagnosis and limited availability of reliable molecular biomarkers. Integrated transcriptomic analysis may facilitate the identification of key regulatory genes involved in tumor progression.
Objective
To identify and validate key regulatory genes associated with ovarian cancer progression through integrated transcriptomic analysis and experimental validation.
Methods
Differential gene expression analysis was conducted using the GSE18520 microarray dataset to compare ovarian cancer tissues with normal ovarian epithelium. Genes with log2 fold change ≥ 1, and adjusted p-value < 0.05 were considered significant. Functional enrichment and protein–protein interaction (PPI) network analyses were performed to prioritize hub genes. FOXQ1 and MCM10 were selected for experimental validation using quantitative real-time polymerase chain reaction (RT-qPCR) in formalin-fixed paraffin-embedded (FFPE) ovarian cancer tissues. Relative expression levels were calculated using the 2⁻ΔΔCt method and normalized to GAPDH.
Results
Transcriptomic analysis identified multiple differentially expressed genes associated with cell cycle regulation, DNA replication, and transcriptional control. FOXQ1 (log2 fold change = +5.00) and MCM10 (log2 fold change = +2.74) were significantly upregulated and occupied central hub positions in the PPI network. RT-qPCR validation confirmed marked overexpression of FOXQ1 (45.3×) and MCM10 (11.3×) in FFPE ovarian cancer tissues.
Conclusion
This integrated transcriptomic and experimental validation study identifies FOXQ1 and MCM10 as key regulators in ovarian cancer, highlighting their potential as biomarkers for disease progression.
Zitieren
APA
Suryandari, D. A., Yunaini, L., Istiadi, K. A., Khatib, A., & Fadilah, F. (2026). Integrated transcriptomic analysis and RT-qPCR validation using FFPE patient tissues reveal the role of FOXQ1 and MCM10 in ovarian cancer. Eurasian Journal of Medicine and Oncology, 10(5), 025470488. https://doi.org/10.36922/ejmo025470488
Vancouver
Suryandari DA, Yunaini L, Istiadi KA, Khatib A, Fadilah F. Integrated transcriptomic analysis and RT-qPCR validation using FFPE patient tissues reveal the role of FOXQ1 and MCM10 in ovarian cancer. Eurasian Journal of Medicine and Oncology. 2026;10(5):025470488. doi:10.36922/ejmo025470488
BibTeX
@article{Suryandari2026,
author = {Suryandari, Dwi A. and Yunaini, Luluk and Istiadi, Khaerunissa Anbar and Khatib, Alfi and Fadilah, Fadilah},
title = {Integrated transcriptomic analysis and RT-qPCR validation using FFPE patient tissues reveal the role of FOXQ1 and MCM10 in ovarian cancer},
journal = {Eurasian Journal of Medicine and Oncology},
year = {2026},
volume = {10},
number = {5},
pages = {025470488},
doi = {10.36922/ejmo025470488}
}
EUVIMED